Form 8-K - Current report:
SEC Accession No. 0000950170-25-086256
Filing Date
2025-06-13
Accepted
2025-06-13 16:30:30
Documents
10
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K olma-20250610.htm   iXBRL 8-K 67509
  Complete submission text file 0000950170-25-086256.txt   173791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20250610.xsd EX-101.SCH 24998
12 EXTRACTED XBRL INSTANCE DOCUMENT olma-20250610_htm.xml XML 4749
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 251047095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)